Antihypertensive mechanisms of chronic captopril or N-acetylcysteine treatment in L-NAME hypertensive rats

Hypertension Research

Volumn 29, Issue 12, 2006, Pages 1021-1027

  Zicha, Josef ^a   Dobešová, Zdenka ^a   Kuneš, Jaroslav ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Endothelium derived hyperpolarizing factor; NO dependent vasodilation; Renin angiotensin system; Sympathetic vasoconstriction

Indexed keywords

ACETYLCYSTEINE; ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; CAPTOPRIL; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PENTOLONIUM TARTRATE; TETRYLAMMONIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; ENZYME INHIBITION; HYPERPOLARIZATION; HYPERTENSION; MALE; NONHUMAN; RAT; SYMPATHETIC TONE; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION; WISTAR RAT;

ACETYLCYSTEINE; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CAPTOPRIL; HYPERTENSION; MALE; NG-NITROARGININE METHYL ESTER; NITROPRUSSIDE; PENTOLINIUM TARTRATE; RATS; RATS, WISTAR; TETRAETHYLAMMONIUM;

EID: 33846820184     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.29.1021     Document Type: Article

References (34)

1. Zanchi A, Schaad NC, Osterheld MC, et al: Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system. Am J Physiol 1995; 268: H2267-H2273.
2. Sander M, Victor RG: Neural mechanisms in nitric-oxide-deficient hypertension. Curr Opin Nephrol Hypertens 1999; 8: 61-73.
3. G-nitro-L-arginine methyl ester. Hypertension 1996; 28: 361-366.
4. Pecháňová O, Bernátová I, Pelouch V, Šimko F: Protein remodelling of the heart in NO-deficient hypertension: the effect of captopril. J Mol Cell Cardiol 1997; 29: 3365-3374.
5. Arnal JF, el Amrani AI, Chatellier G, Menard J, Michel JB: Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension 1993; 22: 380-387.
6. Jover B, Herizi A, Ventre F, Dupont M, Mimran A: Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade. Hypertension 1993; 21: 944-948.
7. ω-nitro-L-arginine methyl ester. Hypertension 1997; 30 (Suppl I): 64-70.
8. 1-adrenergic blockade improves hypertension and renal injury in L-NAME and low-renin L-NAME-DOCA hypertensive rats. Med Sci Monit 2002; 8: BR378-BR384.
9. Gerová M, Török J, Pecháňová O, Matušková J: Rilmenidine prevents blood pressure increase in rats with compromised nitric oxide production. Acta Pharmacol Sin 2004; 25: 1640-1646.
10. Usui M, Egashira K, Tomita H, et al: Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats. Circulation 2000; 101: 305-310.
11. Attia DM, Verhagen AM, Stroes ES, et al: Vitamin E alleviates renal injury, but not hypertension, during chronic nitric oxide synthase inhibition in rats. J Am Soc Nephrol 2001; 12: 2585-2593.
12. ω-nitro-L-arginine methyl ester-treated rats: the role of reactive oxygen species. Hypertens Res 2005; 28: 475-482.
13. Zembowicz A, Hatchett RJ, Radziszewski W, Gryglewski RJ: Inhibition of endothelial nitric oxide synthase by ebselen. Prevention by thiols suggests the inactivation by ebselen of a critical thiol essential for the catalytic activity of nitric oxide synthase. J Pharmacol Exp Ther 1993; 267: 1112-1118.
14. Myers PR, Minor RLJ, Guerra RJ, Bates JN, Harrison DG: Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 1990; 345: 161-163.
15. Pecháňová O, Dobešová Z, Čejka J, Kuneš J, Zicha J: Vasoactive systems in L-NAME hypertension: the role of inducible NO synthase. J Hypertens 2004; 22: 167-173.
16. Kuneš J, Miková D, Dobešová Z, Bíbová J, Hampl V, Zicha J: Vasodilatory mechanisms in L-NAME hypertension. Hypertension 2004; 44: 585 (Abstract).
17. Minami N, Imai Y, Hashimoto J, Abe K: Contribution of vascular nitric oxide to basal blood pressure in conscious spontaneously hypertensive rats and normotensive Wistar Kyoto rats. Clin Sci 1995; 89: 177-182.
18. Berecek KH, Kirk KA, Nagahama S, Oparil S: Sympathetic function in spontaneously hypertensive rats after chronic administration of captopril. Am J Physiol 1987; 252: H796-H806.
19. Kuneš J, Dobešová Z, Zicha J: Angiotensin-dependent sympathetic vasoconstriction in SHR: the effect of captopril treatment in young animals. J Hypertens 2005; 23 (Suppl 342): S234 (Abstract).
20. 1 receptor antagonists. J Hypertens 2002; 20 (Suppl 5): S3-S11.
21. Ganten D, Hermann K, Bayer C, Unger T, Lang RE: Angiotensin synthesis in the brain and increased turnover in hypertensive rats. Science 1983; 221: 869-871.
22. Phillips MI, Kimura B: Brain angiotensin in the developing spontaneously hypertensive rat. J Hypertens 1988; 6: 607-612.
23. Krukoff TL: Central regulation of autonomic function: NO brakes? Clin Exp Pharmacol Physiol 1998; 25: 474-478.
24. Ye S, Zhong H, Duong VN, Campese VM: Losartan reduces central and peripheral sympathetic nerve activity in a rat model of neurogenic hypertension. Hypertension 2002; 39: 1101-1106.
25. Campese VM, Ye S, Zhong H: Downregulation of neuronal nitric oxide synthase and interieukin-1β mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension 2002; 39: 519-524.
26. Veerasingham SJ, Raizada MK: Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives. Br J Pharmacol 2003; 139: 191-202.
27. Nishimura M, Takahashi H, Nanbu A, Sakamoto M, Yoshimura M: Cardiovascular regulation by L-arginine in the brain of rats: role of the brain renin-angiotensin system and nitric oxide. Am J Hypertens 1997; 10: 389-396.
28. Sakima A, Teruya H, Yamazato M, Matayoshi R, Muratani H, Fukiyama K: Prolonged NOS inhibition in the brain elevates blood pressure in normotensive rats. Am J Physiol 1998; 275: R410-R417.
29. Tsuchihashi T, Kagiyama S, Matsumura K, Lin Y, Abe I, Fujishima M: Cardiovascular responses to glutamate and angiotensin II in ventrolateral medulla of hypertension induced by chronic inhibition of nitric oxide. Hypertens Res 2000; 23: 359-364.
30. Nakata T, Takeda K, Harada S, et al: Role of the central nervous system in the development of hypertension produced by chronic nitric oxide blockade in rats. Hypertens Res 2001; 24: 39-45.
31. Pecháňová O, Zicha J, Kojšová S, Dobešová Z, Jendeková L, Kuneš J: Effect of chronic N-acetylcysteine treatment on the development of spontaneous hypertension. Clin Sci 2006; 110: 235-242.
32. Vargas F, Osuna A, Fernandez-Rivas A: Vascular reactivity and flow-pressure curve in isolated kidneys from rats with N-nitro-L-arginine ester-induced hypertension. J Hypertens 1995; 14: 373-379.
33. Bauersachs J, Popp R, Hecker M, Sauer E, Fleming I, Busse R: Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation 1996; 94: 3341-3347.
34. Kanematsu Y, Tsuchiya K, Ohnishi H, et al: Effects of angiotensin II type 1 receptor blockade on the systemic blood nitric oxide dynamics in N-nitro-L-arginine methyl ester-treated rats. Hypertens Res 2006; 29: 369-374.